drugset / Trial / NCT02877537

Measurement of Respiratory Admittance for Pediatric Asthma Diagnosis

NCT02877537

Phase 4 Completed 177 enrolled Central Hospital, Nancy, France
Non-randomizedParallel-groupOpen-labelDiagnostic

Summary

The purpose is to characterize the change of respiratory admittance induced by salbutamol inhalation in children and young adults. A variation threshold will be fixed to distinguish asthmatic and healthy subjects. This project could allow a better identification of asthmatic individuals needing a treatment, a reduction of morbidity of asthma, a reduction of unnecessary treatments administered in individuals with respiratory but not asthmatic symptoms, a better comprehension of bronchial hyperreactivity and its role in asthmatic disease.

Timeline

Start
2008-10
Primary completion
2012-04
Completion
2012-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Salbutamol Unknown 100 ug Inhaled

Indications